John A. Latham, Chief Scientific Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 10,000 shares at $30.02 ($300K) on 2016-06-01, disclosed to the SEC on 2016-06-03.
Open-market sale of $300k ALDR by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALDR | SELL | 2018-08-02 | $489K | — | Filing → |
| ALDR | SELL | 2018-07-03 | $387K | — | Filing → |
| ALDR | SELL | 2018-06-05 | $446K | — | Filing → |